Saturday 17 October 2026
Export NXGL’s income statement to Excel — free account
NexGel, Inc.
NXGL Healthcare Medical Instruments & Supplies
NexGel, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 31.5% from fiscal 2024. In the quarter to June 2026, revenue grew 27.8%, EPS fell 344.4%, free cash flow fell 432.3% and total debt rose 353.8%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.
5.59
0.41
+7.92%
Follow NXGL
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 5 | 5 | 2 | 3 | 5 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | 18.87 | 29.08 | 27.76 | 68.80 | 24.63 |
P/S ratio |
— | 187.25 | 187.25 | 187.25 | 100.29 | 73.50 | 62.42 | 66.86 | 22.14 |
Altman Z″-Score (non-manufacturers) |
— | — | (14.82) | (13.13) | 4.53 | 1.35 | (4.38) | (4.63) | (6.91) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | (46.34) | (3.32) | (0.77) | (1.98) | (3.41) |
P/Operating CF |
— | (401.00) | (401.00) | (401.00) | (129.95) | (231.93) | (434.82) | (676.22) | 900.00 |
P/B ratio |
— | 433.31 | 433.31 | 433.31 | 12.87 | 19.71 | 49.41 | 95.54 | 51.71 |
Price to Tangible BV |
— | 1,542.07 | 1,542.07 | 1,542.07 | 13.25 | 20.60 | 68.76 | 140.14 | 82.06 |
EV/Sales |
— | 186.38 | 186.38 | 186.38 | 91.86 | 70.41 | 61.89 | 66.76 | 22.12 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (105.48) | (105.48) | (105.48) | (51.75) | (48.19) | (78.20) | (150.00) | (192.72) |
EV/FCF |
— | (82.54) | (82.54) | (82.54) | (47.15) | (48.60) | (64.36) | (134.58) | (174.49) |
Quick Ratio |
— | 0.08 | 0.45 | 0.08 | 4.69 | 7.95 | 1.31 | 1.11 | 0.59 |
Current Ratio |
— | 0.89 | 0.64 | 0.27 | 4.82 | 8.74 | 1.98 | 2.07 | 1.47 |
Net Debt/EBITDA |
— | 0.00 | (0.35) | (0.10) | 24.97 | 3.32 | 0.67 | 0.32 | 0.13 |
Debt/Assets |
0.00% | 0.00% | 48.52% | 11.34% | 1.57% | 2.59% | 5.15% | 8.15% | 6.99% |
Debt/Equity |
— | 0.00 | 2.41 | 3.61 | 0.02 | 0.04 | 0.10 | 0.15 | 0.15 |
Asset Turnover |
— | 5.99 | 0.55 | 0.33 | 0.16 | 0.15 | 0.40 | 0.83 | 1.07 |
Operating CF/Net income |
— | 0.82 | 0.94 | 0.80 | 0.64 | 0.63 | 1.03 | 1.18 | 0.44 |
Capex/Depreciation |
— | 0.00 | 0.00 | (6.00) | (0.13) | (0.07) | (3.08) | (0.67) | (0.09) |
Interest Coverage |
— | — | — | (282.50) | (1.33) | (2.51) | (231.80) | (43.88) | (98.59) |
| — | (571.26%) | (581.85%) | (1,003.99%) | (70.91%) | (48.13%) | (49.32%) | (58.35%) | (54.69%) | |
| — | (510.96%) | (146.29%) | (109.19%) | (44.80%) | (34.72%) | (31.09%) | (31.34%) | (27.98%) | |
ROIC |
— | 0.00% | 0.00% | (478.81%) | 0.00% | (161.46%) | (72.95%) | (42.98%) | (45.90%) |
Return on Tangible Assets |
— | (1,225.97%) | (210.86%) | 544.23% | (36.64%) | (64.42%) | (78.89%) | (67.58%) | (89.90%) |
Average Days of Receivables |
— | 5.61 | 51.92 | 39.53 | 49.18 | 39.57 | 56.50 | 39.20 | 21.51 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 2.00% | 17.92% | 2.52% | 0.90% | 0.02% |
Selling, General and Administrative Expense of Revenue |
— | 107.23% | 245.89% | 292.14% | 164.22% | 158.06% | 91.66% | 71.64% | 68.81% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.16 | 0.02 | 0.03 | 0.15 | 0.18 | 0.17 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 34.42% | 18.38% | 14.55% | 5.31% | 4.22% | 5.73% |
Graham Net Nets |
— | (0.01) | (0.01) | (0.01) | 0.06 | 0.03 | 0.00 | 0.00 | 0.00 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (2.69%) | (2.69%) | (2.69%) | (2.77%) | (3.15%) | (1.24%) | (0.56%) | (1.18%) |
Free Cash Flow Yield |
— | (1.21%) | (1.21%) | (1.21%) | (1.94%) | (1.97%) | (1.54%) | (0.74%) | (0.57%) |
Revenue per Share |
— | 0.44 | 0.05 | 0.30 | 0.52 | 0.37 | 0.72 | 1.33 | 1.45 |
Operating CF per Share |
— | (0.31) | (0.13) | (0.80) | (0.92) | (0.54) | (0.57) | (0.59) | (0.17) |
Capex per Share |
— | 0.00 | 0.00 | (0.14) | (0.09) | (0.02) | (0.12) | (0.07) | (0.01) |
Free Cash Flow per Share |
— | (0.31) | (0.13) | (0.94) | (1.01) | (0.55) | (0.69) | (0.66) | (0.18) |
Cash per Share |
— | 0.00 | 0.02 | 0.01 | 4.48 | 1.19 | 0.48 | 0.28 | 0.13 |
Shareholders Equity per Share |
— | 0.06 | 0.03 | 0.03 | 4.06 | 1.37 | 0.91 | 0.93 | 0.62 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.06 | 0.03 | 0.03 | 4.06 | 1.37 | 0.91 | 0.93 | 0.62 |
Free Cash Flow |
— | (1.54) | (1.81) | (2.11) | (3.02) | (3.09) | (3.93) | (4.31) | (1.38) |
Working Capital |
— | (0.05) | (0.29) | (0.97) | 11.04 | 6.65 | 2.50 | 2.64 | 1.38 |
Capital Expenditures |
— | — | — | (0.31) | (0.27) | (0.10) | (0.70) | (0.44) | (0.07) |
Net Current Asset Value |
— | (0.10) | (1.00) | (1.82) | 9.03 | 4.79 | 0.26 | 0.21 | (1.23) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | 0.00 | 0.46 | 0.17 | 0.05 | 0.17 | 0.05 | 0.01 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 1.61 | 0.06 | 0.09 | 2.83 | 1.99 | 0.15 | 0.30 | 0.38 |
Cash ROIC |
— | (549.47%) | (116.43%) | (588.58%) | (11.76%) | (21.28%) | (46.93%) | (49.08%) | (20.64%) |
Accounts Receivable Turnover |
— | 32.54 | 10.54 | 7.70 | 11.00 | 9.50 | 9.56 | 11.10 | 14.22 |
Accounts Payable Turnover |
— | 5.18 | 2.63 | 1.65 | 3.38 | 6.91 | 4.96 | 4.71 | 5.36 |
Inventory Turnover |
— | 16.15 | 8.21 | 5.58 | 5.89 | 4.52 | 4.08 | 3.87 | 3.58 |
Average Days of Payables |
— | 33.16 | 212.02 | 248.88 | 60.08 | 53.98 | 121.14 | 79.39 | 68.07 |
Days of Inventory on Hand |
— | 21.33 | 46.98 | 88.13 | 68.84 | 102.25 | 129.59 | 107.60 | 111.48 |
Average Receivables |
— | 0.07 | 0.07 | 0.09 | 0.14 | 0.22 | 0.43 | 0.78 | 0.80 |
Average Payables |
— | 0.33 | 0.33 | 0.58 | 0.46 | 0.26 | 0.75 | 1.26 | 1.29 |
Average Inventory |
— | 0.11 | 0.11 | 0.17 | 0.26 | 0.40 | 0.91 | 1.54 | 1.93 |
Average Assets |
— | 0.37 | 1.31 | 2.07 | 9.62 | 13.67 | 10.16 | 10.47 | 10.72 |
Average Common Equity |
— | 0.33 | 0.33 | 0.23 | 6.08 | 9.86 | 6.40 | 5.62 | 5.49 |
Columns are period end dates